Mavorixafor Patent Expiration
Mavorixafor was first introduced by X4 Pharmaceuticals Inc
Mavorixafor Patents
Given below is the list of patents protecting Mavorixafor, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xolremdi | US10548889 | Compositions of CXCR4 inhibitors and methods of preparation and use | Dec 11, 2038 | X4 Pharms |
| Xolremdi | US10610527 | Methods for treating immunodeficiency disease | Dec 22, 2036 | X4 Pharms |
| Xolremdi | US10953003 | Methods for treating cancer | Dec 14, 2036 | X4 Pharms |
| Xolremdi | US11045461 | Compositions of CXCR4 inhibitors and methods of preparation and use | Dec 11, 2038 | X4 Pharms |
| Xolremdi | US11219621 | Methods for treating immunodeficiency disease | Dec 22, 2036 | X4 Pharms |